Status:
COMPLETED
One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19
Lead Sponsor:
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Collaborating Sponsors:
Barcelona Supercomputing Center
Carlos III Health Institute
Conditions:
Acute Respiratory Distress Syndrome
Severe Pneumonia
Eligibility:
All Genders
Brief Summary
The latest epidemiological data published from Chine reports that up to 30% of hospital-admitted patients required admission to intensive care units (ICU). The cause for ICU admission for most patient...
Detailed Description
Objective and Purpose of Study 1. The main objective is to determine risks factors and prognosis of patients with COVID-19 infection who have been admitted to Spanish ICUs between the beginning and e...
Eligibility Criteria
Inclusion
- 1\. Laboratory-confirmed COVID-19 infection with either real-time PCR or Next Generation Sequencing (NGS)
- 2\. Admission to intensive care unit
Exclusion
- 1\. Patients admitted to COVID-19-negative ICU
Key Trial Info
Start Date :
May 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
8500 Patients enrolled
Trial Details
Trial ID
NCT04457505
Start Date
May 8 2020
End Date
December 31 2021
Last Update
July 21 2022
Active Locations (31)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain, 08907
2
Hospital de Mataró
Mataró, Barcelona, Spain, 08304
3
Hospital General de Cataluña
Sant Cugat del Vallès, Barcelona, Spain, 08195
4
Hospital Infanta Margarita de Cabra
Cabra, Córdoba, Spain, 14940